AGP Picks
View all

Get your fresh news on science and technology in Malta

Provided by AGP

Got News to Share?

Technology Center Malta: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Center Malta.

Press releases published on April 29, 2026

Rein Therapeutics Provides Clinical Trial Update for Phase 2 RENEW Study of LTI-03 in Idiopathic Pulmonary Fibrosis
Komprise Awarded Elastic Shares Patent to Accelerate AI ingestion, Metadata Extraction & Data Mobilization for Unstructured Data
Calidi Biotherapeutics Announces Strategic Partnership with TransferAI to Drive Efficiencies in the IND Submission Process for CLD-401 Using Agentic AI
SureShotFX Marks Milestone Expansion for Providing Trading Alerts & Automated Tools
Cronos Group Inc. to Hold Virtual 2026 Annual Meeting of Shareholders
Roadzen’s drivebuddyAI Wins $2.5 Million Contract to Bring AI-Powered Safety to 3,000 Truck Fleet
Sagtec Global Limited Achieves Record Revenue of US$19.1 Million in Fiscal Year 2025, Marking 49% Year-over-Year Growth
Ocugen to Host Conference Call on Tuesday, May 5 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2026 Financial Results
OKYO CEO and CSO to Present and Leadership Team to Participate at Upcoming Scientific Conferences in May
ADMA Biologics to Report First Quarter 2026 Financial Results on May 6, 2026
EyePoint to Report First Quarter 2026 Financial Results on May 6, 2026
Energous to Report First Quarter 2026 Financial Results and Host Conference Call
Aeluma to Announce Third Quarter Fiscal Year 2026 Financial Results on May 13, 2026
Ocular Therapeutix™ Announces First Patient Enrolled in SOL-X Long-Term Extension Trial for AXPAXLI™ in Wet AMD
Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Plans for an Adaptive Phase 2 Field Study of TNX-4800 (anti-Borrelia OspA monoclonal antibody) for the Prevention of Lyme Disease at the 4th Annual Ticks and Tickborne Diseases Symposium…
Amarin Reports 2026 First Quarter Financial Results
Intellia Therapeutics Announces Pricing of Public Offering of Common Stock
Teva Delivers Strong Q1 2026 Results Driven by Innovative Portfolio Growth and Disciplined Execution
Denovo Announces Issuance of U.S. Patent of Novel Genetic Biomarker ANK3 (DGM4™) for Liafensine (DB104)
Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva’s Pivot to Growth Strategy

Share us

on your social networks:

Sign up for:

Technology Center Malta

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.